A new study indicates that noninvasive prenatal screening (NIPS) performed using a low-cost form of whole genome sequencing can detect the risk in pregnant mothers of transmitting cytomegalovirus (CMV ...
The Australian patent represents the first patent granted for the Company's new point-of-care testing platformSALT LAKE CITY, ...
Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...
In Franklin Mountains State Park, infected bugs emerged from their typical wild refuges: rocky crevices, dry arroyos, and ...
Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the ...
Initiation of eAArly DETECT 2 - U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over ...
GraftAssure™ technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first Canadian ...
Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...
This study offers important insight into the pathogenic basis of intragenic frameshift deletions in the carboxy-terminal domain of MECP2, which account for some Rett syndrome cases, yet similar ...
IPOs don’t always get the attention they deserve, yet they play a vital role in renewing the stock market. They bring new ...
The Asian longhorn tick is native to Japan, China, Korea, and parts of Russia. Australia and New Zealand imported the tick a ...
GraftAssure technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first Canadian siteGraftAssureDx FDA IVD approval application 95% complete at yea ...